FDA Inspection
Wuhan Wuyao Pharmaceutical Co., Ltd.Wuhan Wuyao Pharmaceutical Co., Ltd. – FDA Inspection, May 13, 2016
Record Details
This FDA Inspection record concerns Wuhan Wuyao Pharmaceutical Co., Ltd., with an inspection on May 13, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 13, 2016
- Product Type
- Drugs
View Company Profile
ID · 3f868dc4-2481-44cc-85c0-973e69a02356
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 972877
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Wuhan Wuyao Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | Not classified | Office of Inspections and Investigations | |
| March 9, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Wuhan Wuyao Pharmaceutical Co., Ltd.
- FDA Inspection 1265191 - 2025-03-07
- FDA Inspection 1050824 - 2018-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.